A Fortune 500 Pharmaceutical Company known for using science-based innovation to contrive breakthrough treatments, turned to ktMINE to assist in uncovering research on expected and reasonable royalty rates.
For many, commercializing IP is a time-consuming task. It is also necessary to generate revenues and keep organizations at the forefront of research and innovation. However, without access to the right information, the probability of failure exponentially increases. Historically, licensing professionals have had to spend hours looking for potential licensing partners, comparable deals and similar patents. Many individual